Welcome to our dedicated page for Colony Bankcorp SEC filings (Ticker: CBAN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Colony Bankcorp Inc. finances Georgia’s main streets, from agri-business combines to downtown construction loans, and its SEC disclosures mirror that diverse footprint. If you need Colony Bankcorp insider trading Form 4 transactions or want the loan-to-deposit ratio buried on page 80 of the Colony Bankcorp annual report 10-K simplified, you are in the right place.
Stock Titan’s AI reads every paragraph the moment it hits EDGAR. That means you see Colony Bankcorp Form 4 insider transactions real-time, a Colony Bankcorp quarterly earnings report 10-Q filing with side-by-side credit-quality charts, and Colony Bankcorp 8-K material events explained before the market fully reacts. Our AI-powered summaries translate allowance-for-loan-loss tables into plain English, so understanding Colony Bankcorp SEC documents with AI is faster than scanning hundreds of pages.
Here’s how professionals use this page:
- Credit analysts open the latest Colony Bankcorp earnings report filing analysis to compare non-performing assets quarter-over-quarter.
- Portfolio managers set alerts for Colony Bankcorp executive stock transactions Form 4 to monitor insider sentiment.
- Governance specialists pull the Colony Bankcorp proxy statement executive compensation section to benchmark pay at regional banks.
All filings�10-K, 10-Q, 8-K, Forms 3/4/5, and proxies—are indexed, searchable, and refreshed in real time. Whether you’re tracking dividend capacity, branch acquisitions, or loan-loss provisions, you’ll find Colony Bankcorp SEC filings explained simply, with AI-generated highlights that let you focus on decisions, not document hunting.
Colony Bankcorp Inc. (CBAN) Form 4 highlights: Director Matthew D. Reed reported the grant of 969 restricted shares on 07/15/2025. Following the award, he now directly owns 16,736 common shares, up roughly 6% from the pre-grant level (~15,767). In addition, Reed holds 448 shares indirectly through an IRA for Kennedy K. Reed. No derivative securities, sales, or open-market purchases were disclosed.
The filing reflects a routine equity-based compensation grant and modestly increases insider ownership, which can align director incentives with shareholder interests. However, because the shares were granted (not purchased with personal funds), the transaction’s immediate signaling value is limited. No other material events, financial metrics, or changes to ownership structure were reported.